MedTrace Logo

A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia

NCT01511224 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2012-01-18

No results posted yet for this study

Summary

Extensively and multi-drug resistant A. baumannii (AB) represent an emerging threat in hospitals locally and worldwide. There is lack of prospective comparative clinical data to guide optimal strategy for treating such infections. Since it remains unclear how to treat bacteremia caused by AB, the present study aims to enroll patients at multiple sites with extensively drug resistant Acinetobacter species bacteremia receiving different combination therapy to assess treatment outcomes and analyze risk factors associated with mortality.

Conditions

  • Acinetobacter Bacteraemia

Sponsors & Collaborators

  • Far Eastern Memorial Hospital

    collaborator OTHER

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Hsin-Yun Sun, MD · National Taiwan University Hospital

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-12-31
Completion
2013-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01511224 on ClinicalTrials.gov